Literature DB >> 192453

Glycosyltransferases and glycosidases in Morris hepatomas.

C H Bauer, P Vischer, H Grünholz, W Reutter.   

Abstract

The following three parameters were studied in Morris hepatomas of different growth rates: (a) the specific activity of guanosine dephosphate (GDP)-fucose:glycoprotein fucosyltransferase and cytidine monophosphate (CMP)-N-acetylneuraminic acid:glycoprotein sialyltransferase, (B) the content of GDP-fucosee and CMP-N-acetylneuraminic acid, and (c) the activity of alpha-L-fucosidase and neuraminidase. Fucosyltrasferase activities were significantly elevated in all hepatomas investigated. Especially high levels of enzyme were measured in the rapidly growing tumors 7777, 66, and 3924A. The increase varied between 2- and 3-fold when compared with the corresponding host liver. Conversely, the activity of the sialytransferase was greatly decreased in all hepatoma lines with a rapid or intermediate growth rate. In the fast-growing tumor 9618A2, the activity was reduced to 8%. GDP-fucose and CMP-N-acetylneuraminic acid were determined by the isotope dilution technique. In normal rat liver from Buffalo or ACl rats, the concentration of GDP-fucose was 6.5+/-0.9 and 9.5+/-1.1nmoles/g, wet weight, respectively. In the fast-growing hepatomas 3924A and 9121, levels up to 21.5 nmoles/g, wet weight, were found, However, the content of CMP-N-acetylneuraminic acid in hepatomas was indluenced to a lesser extent by the degree of differentiation of the tumor. In the most rapidly growing tumor, 9618A2, a level of alpha-L- fucosidase seven times higher than in host liver was determined. Moreover, there existed a correlation bewteen the age of the hepatoma and enzyme activity. Within the 2nd week after inoculation, fucosidase activity increased from 130 to 343 nmoles/hr/mg of protein. Neuraminidase was measured in a new linked assay system. The activity of this enzyme was lowered by 50% or was at least unchanged when compared to the activity in host liver. Our results indicate that specific alterations of fucose metabolism are a characteristic feature of Morris hepatomas.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 192453

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  8 in total

1.  [Glycoproteins: their biological and clinical significance. II (author's transl)].

Authors:  E Köttgen; C Bauer; W Reutter; W Gerok
Journal:  Klin Wochenschr       Date:  1979-03-01

2.  Relation between raised concentrations of fucose, sialic acid, and acute phase proteins in serum from patients with cancer: choosing suitable serum glycoprotein markers.

Authors:  G A Turner; A W Skillen; P Buamah; D Guthrie; J Welsh; J Harrison; A Kowalski
Journal:  J Clin Pathol       Date:  1985-05       Impact factor: 3.411

Review 3.  Serum-sialyltransferase activity in cancer patients.

Authors:  P G Berge; A Wilhelm; H Schriewer; G Wüst
Journal:  Klin Wochenschr       Date:  1982-05-03

4.  Simultaneous determination of six tumor markers in patients with prostatic carcinoma and bladder tumors.

Authors:  B Schwemmer; W Schütz; R M Kuntz; A Lehmer
Journal:  Urol Res       Date:  1985

Review 5.  Carbohydrate structure in tumor immunity.

Authors:  C L Reading; J T Hutchins
Journal:  Cancer Metastasis Rev       Date:  1985       Impact factor: 9.264

6.  Genotyping the GALNT14 gene by joint analysis of two linked single nucleotide polymorphisms using liver tissues for clinical and geographical comparisons.

Authors:  Kung-Hao Liang; Pei-Ching Yang; Chau-Ting Yeh
Journal:  Oncol Lett       Date:  2014-09-05       Impact factor: 2.967

7.  Membrane-associated sialidase of rat liver and its decrease in hepatomas.

Authors:  J Sagawa; T Miyagi; S Tsuiki
Journal:  Jpn J Cancer Res       Date:  1988-01

8.  Overexpression of UDP-Glucose 4-Epimerase Is Associated with Differentiation Grade of Gastric Cancer.

Authors:  Maria de Fátima Deodato de Souza; Antônio Felix da Silva Filho; Amanda Pinheiro de Barros Albuquerque; Michael Williams Leal Quirino; Mário Sérgio de Souza Albuquerque; Marina Ferraz Cordeiro; Mário Rino Martins; Ivan da Rocha Pitta; Antônio Roberto Lucena-Araujo; Maira Galdino da Rocha Pitta; Moacyr Jesus Barreto de Melo Rêgo
Journal:  Dis Markers       Date:  2019-11-20       Impact factor: 3.434

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.